Complete remission of relapsed ATXN2L::JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a child.

Saved in:
Bibliographic Details
Title: Complete remission of relapsed ATXN2L::JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a child.
Authors: Cohen T; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA. drort@mskcc.org., Zhou T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Edema U; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Pandit-Taskar N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA., Forlenza C; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA., Price A; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA., Ramaswamy K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA., Trippett T; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA., Sulis ML; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA., Boelens JJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA., Lim MS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA.
Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Feb 14; Vol. 10 (1). Date of Electronic Publication: 2026 Feb 14.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2397-768X
DOI:10.1038/s41698-026-01299-z